Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q874091> ?p ?o }
Showing triples 1 to 75 of
75
with 100 triples per page.
- Q874091 subject Q7112253.
- Q874091 subject Q8301171.
- Q874091 subject Q8401402.
- Q874091 abstract "Intercell AG was a biotechnology company based in Vienna which focused on the development of modern prophylactic and therapeutic vaccines against infectious diseases. Intercell was formed in 1998 as a spin-off of the Research Institute of Molecular Pathology (IMP) in Vienna.It employs 400 people in Austria, Scotland and the United States.It has been listed on the Vienna Stock Exchange since February 28, 2005. In 2008, Intercell signaled its intent to acquire Maryland-based Iomai, a developer of needle-free vaccination technology.Intercell cooperates with pharmaceutical companies like Novartis, Merck and Sanofi-Aventis on vaccine production.The most important projects of Intercell are: Vaccine against Japanese encephalitis (approved in Europe, America and Australia) Therapeutic vaccine against hepatitis C (in clinical phase II) Antigen identification program and adjuvant technologies. Vaccine Enhancement Patch to improve prevention against pandemic influenza (in collaboration with U.S. Department of Health and Human Services, in clinical phase II)↑ 1.0 1.1 1.2 1.3 1.4 1.5 ↑ ↑ ↑ ↑ ↑ ↑ ↑".
- Q874091 assets "2.252E8".
- Q874091 equity "1.211E8".
- Q874091 extinctionYear "2013".
- Q874091 fate "Merged with Vivalis SA".
- Q874091 foundingYear "1998".
- Q874091 industry Q7108.
- Q874091 internationally "true".
- Q874091 keyPerson Q140686.
- Q874091 keyPerson Q484876.
- Q874091 locationCity Q1741.
- Q874091 locationCountry Q40.
- Q874091 netIncome "2.552E8".
- Q874091 numberOfEmployees "410".
- Q874091 operatingIncome "2.512E8".
- Q874091 product Q134808.
- Q874091 revenue "3.42E7".
- Q874091 type Q22084735.
- Q874091 wikiPageExternalLink www.intercell.com.
- Q874091 wikiPageWikiLink Q103537.
- Q874091 wikiPageWikiLink Q134808.
- Q874091 wikiPageWikiLink Q1391.
- Q874091 wikiPageWikiLink Q140686.
- Q874091 wikiPageWikiLink Q154869.
- Q874091 wikiPageWikiLink Q158205.
- Q874091 wikiPageWikiLink Q17005388.
- Q874091 wikiPageWikiLink Q1741.
- Q874091 wikiPageWikiLink Q1930860.
- Q874091 wikiPageWikiLink Q22084735.
- Q874091 wikiPageWikiLink Q247489.
- Q874091 wikiPageWikiLink Q2840.
- Q874091 wikiPageWikiLink Q30612.
- Q874091 wikiPageWikiLink Q357896.
- Q874091 wikiPageWikiLink Q40.
- Q874091 wikiPageWikiLink Q484876.
- Q874091 wikiPageWikiLink Q507154.
- Q874091 wikiPageWikiLink Q507443.
- Q874091 wikiPageWikiLink Q666941.
- Q874091 wikiPageWikiLink Q698535.
- Q874091 wikiPageWikiLink Q7108.
- Q874091 wikiPageWikiLink Q7112253.
- Q874091 wikiPageWikiLink Q738292.
- Q874091 wikiPageWikiLink Q759969.
- Q874091 wikiPageWikiLink Q8301171.
- Q874091 wikiPageWikiLink Q8401402.
- Q874091 wikiPageWikiLink Q942326.
- Q874091 assets "2.252E8".
- Q874091 equity "1.211E8".
- Q874091 fate "Merged with Vivalis SA".
- Q874091 foundation "1998".
- Q874091 industry Q7108.
- Q874091 intl "yes".
- Q874091 keyPeople "Thomas Lingelbach , Michel Gréco".
- Q874091 locationCity Q1741.
- Q874091 locationCountry Q40.
- Q874091 name "Intercell AG".
- Q874091 numEmployees "410".
- Q874091 products "Development of vaccines".
- Q874091 revenue "3.42E7".
- Q874091 type Q22084735.
- Q874091 type Organization.
- Q874091 type Agent.
- Q874091 type Company.
- Q874091 type Organisation.
- Q874091 type Agent.
- Q874091 type SocialPerson.
- Q874091 type Thing.
- Q874091 type Q43229.
- Q874091 comment "Intercell AG was a biotechnology company based in Vienna which focused on the development of modern prophylactic and therapeutic vaccines against infectious diseases. Intercell was formed in 1998 as a spin-off of the Research Institute of Molecular Pathology (IMP) in Vienna.It employs 400 people in Austria, Scotland and the United States.It has been listed on the Vienna Stock Exchange since February 28, 2005.".
- Q874091 label "Intercell".
- Q874091 homepage www.intercell.com.
- Q874091 name "Intercell AG".